Brian K. Beeler has been appointed general counsel at Horizon Pharma, reporting to Timothy P. Walbert, chairman, president and chief executive officer. Mr. Beeler has also joined the company’s Executive Committee.

Mr. Beeler joined the company in 2013 as associate general counsel and chief compliance officer and was promoted to senior vice president, legal and chief compliance officer in January 2015. He has more than 15 years of experience providing counsel to businesses in the healthcare and life sciences industries.

Previously, Mr. Beeler served as associate general counsel for Fenwal, Inc., a global life sciences manufacturer of products for transfusion medicine, and was senior counsel, business development, commercial and R&D at TAP Pharmaceuticals and Takeda Pharmaceuticals North America.  

“Since Brian joined Horizon Pharma, he has been instrumental in guiding our legal and compliance functions, which are vital to our long-term success,” said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc. “I have absolute confidence that as general counsel, Brian will continue to provide exemplary guidance and to help us navigate our growing business.”

Also, Tim Ayers has been named vice president and chief compliance officer. Mr. Ayers has extensive experience in the biopharma industry, and most recently served as a principal and vice president at the legal practice of Porzio, Bromberg & Newman in the Life Sciences Compliance, Commercialization and Regulatory Counseling Department. Previously, he served as vice president and chief compliance officer at Dendreon Corp., where he was responsible for the development and implementation of a company-wide compliance program in the U.S. and EU.